Literature DB >> 12434200

Long-term treatment with angiotensin II type 1 receptor antagonist, CV-11974, restores beta-catenin mRNA expression in volume-overloaded rabbit hearts.

Makoto Itoh1, Yasuchika Takeishi, Shigekazu Nakada, Takuya Miyamoto, Yuichi Tsunoda, Hiroki Takahashi, Isao Kubota, Hitonobu Tomoike.   

Abstract

This study aimed to search genes altered in expression after long-term treatment with the angiotensin II type 1 receptor (AT1) antagonist, CV-11974, in volume-overloaded hearts. Arteriovenous shunt was made between the common carotid artery and jugular vein in Japanese White rabbits. Shunt-operated rabbits were randomly treated with CV-11974 or vehicle for 6 weeks, starting 6 weeks after surgery. As controls, sham-operated rabbits were given vehicle. Total RNA was prepared from each left ventricular myocardium. Using differential display, we screened one cDNA encoding human beta-catenin, in which the expression was upregulated after CV-11974 administration in shunt rabbit hearts. Beta-catenin is a molecule that exists in the intercalated disks and also works in cytoplasm as a major component of Wnt signaling. We then examined mRNA expressions of beta-catenin and connexin43 by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR). The mRNA expressions of beta-catenin and connexin43 were markedly depressed in shunt-operated animals given vehicle compared with sham-operated animals (P < 0.01). These results suggest that downregulation of beta-catenin and connexin43 expression might be involved in the process of ventricular remodeling by volume overload. The RT-PCR also demonstrated that beta-catenin mRNA expression was significantly higher in shunt rabbits treated with CV-11974 than in those given vehicle (P < 0.05). These data suggest that volume overload may downregulate beta-catenin expression by an AT1 receptor-mediated pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434200     DOI: 10.1007/s003800200040

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  7 in total

Review 1.  Winding through the WNT pathway during cellular development and demise.

Authors:  F Li; Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2006-01       Impact factor: 2.303

Review 2.  Electrical and structural remodeling in left ventricular hypertrophy-a substrate for a decrease in QRS voltage?

Authors:  Ljuba Bacharova
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

Review 3.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

4.  The Renin-Angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle.

Authors:  Wajid Hussain; Pravina M Patel; Rasheda A Chowdhury; Candido Cabo; Edward J Ciaccio; Max J Lab; Heather S Duffy; Andrew L Wit; Nicholas S Peters
Journal:  J Cardiovasc Electrophysiol       Date:  2010-11

Review 5.  WNT signaling in atrial fibrillation.

Authors:  Carmen Wolke; Elmer Antileo; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

6.  Inhibition of GTPase Rac1 expression by vitamin D mitigates pressure overload-induced cardiac hypertrophy.

Authors:  Ali Moradi; Abdulbaset Maroofi; Mahdie Hemati; Tahmine Hashemzade; Nasrin Alborzi; Fatemeh Safari
Journal:  Int J Cardiol Heart Vasc       Date:  2021-11-30

Review 7.  A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43.

Authors:  Motohiro Okada; Kouji Fukuyama; Takashi Shiroyama; Masahiko Murata
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.